APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 139 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,408 | +336.9% | 115,889 | +945.6% | 0.01% | +500.0% |
| Q2 2023 | $1,009 | -56.7% | 11,084 | -68.6% | 0.00% | -66.7% |
| Q1 2023 | $2,328 | -46.9% | 35,304 | -58.4% | 0.00% | -50.0% |
| Q4 2022 | $4,386 | -99.9% | 84,820 | +84.0% | 0.01% | +20.0% |
| Q3 2022 | $3,148,000 | +478.7% | 46,096 | +282.8% | 0.01% | +400.0% |
| Q2 2022 | $544,000 | +300.0% | 12,043 | +348.9% | 0.00% | – |
| Q1 2022 | $136,000 | +240.0% | 2,683 | +117.1% | 0.00% | – |
| Q3 2021 | $40,000 | -28.6% | 1,236 | -6.6% | 0.00% | – |
| Q1 2021 | $56,000 | -92.6% | 1,324 | -90.0% | 0.00% | -100.0% |
| Q4 2020 | $754,000 | -40.5% | 13,189 | -75.0% | 0.00% | -50.0% |
| Q3 2019 | $1,268,000 | – | 52,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |